Hematopoietic Cell Therapy Standards

The objective of the FACT-JACIE Standards is to promote quality medical and laboratory practice in hematopoietic progenitor cell transplantation and other therapies using hematopoietic derived cellular products. The scope of the Standards includes hematopoietic progenitor cells (HPCs), nucleated cells or mononuclear cells from any hematopoietic tissue source collected for therapeutic use other than as HPCs, immune effector cells (IECs), and genetically modified cells.

Cellular Therapy Accreditation Process Requirements

The Crosswalk between the 8^th Edition and 9^th Edition is included in the Ninth Edition FACT-JACIE International Standards for Hematopoietic Cellular Therapy Product Collection, Processing, and Administration.

Eighth Edition

• Eighth Edition FACT-JACIE International Standards for Hematopoietic Cellular Therapy Product Collection, Processing and Administration, Version 8.1
• Eighth Edition FACT-JACIE Hematopoietic Cellular Therapy Accreditation Manual, Version 8.3
• Purchase Print Version of the Standards and Accreditation Manual
• Hematopoietic Cellular Therapy Document Submission Requirements, Eighth Edition
• Crosswalk - Seventh to Eighth Edition
• Crosswalk - Eighth to Seventh Edition
• Summary of Changes to Eighth Edition Standards
• HCT Self-Assessment Tool, Eighth Edition
• OneNote HCT Self-Assessment Tool, Eighth Edition
• HCT Training and Competency Form, Eighth Edition